Application of CDC20 in osteogenic differentiation of mesenchymal stem cells
A technology of 1. CDC20 and mesenchymal stem cells, applied in the field of stem cells, can solve problems such as increased expression and unclear effect of CDC20 on bone formation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] Example 1 Changes in the expression level of CDC20 during the osteogenic differentiation of human bone marrow mesenchymal stem cells
[0032] Cell culture:
[0033] Human bone marrow mesenchymal stem cells were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA). Human bone marrow mesenchymal stem cells were collected from three different donors and were approved by the Ethics Committee of Peking University Stomatological Hospital. Proliferation medium is α-MEM medium (including 10% fetal bovine serum, 100 U / ml penicillin, 100 μg / ml streptomycin). Osteogenic differentiation medium includes proliferation medium plus 0.2mM vitamin C, 10mM sodium β-glycerophosphate and 100nM dexamethasone. Cells were seeded in culture dishes at 37°C, 5% CO 2 Cultured under conditions, the medium was changed once every 3 days. When the cells grew to 80% confluent state under an inverted microscope, they were digested and passaged with 0.25% trypsin, and added to the mediu...
Embodiment 2
[0062] Effects of inhibiting or overexpressing CDC20 on the osteogenic differentiation of human bone marrow mesenchymal stem cells
[0063] Plasmid expression, siRNA and lentiviral transfection:
[0064] The overexpression plasmid vector Vector and the overexpression CDC20 plasmid WT-CDC20 were purchased from ADDGENE Company. When the cells grew to 70%-80% confluence, the plasmid was transferred into the mesenchymal stem cells using the transfection reagent Lipo3000 according to the instructions, and the cells were collected after 24-36 hours for subsequent experiments. siRNA (small interfering RNA) was used to silence the expression of genes. The control siRNA and CDC20si were purchased from Shanghai Gemma Company. For mesenchymal stem cells, cells were collected at an appropriate time for subsequent experiments. The lentivirus can be integrated into the genome for gene interference. The knockdown control and CDC20sh were purchased from Shanghai Gemma Company. 72h after tr...
Embodiment 3
[0096] Knockdown of CDC20 regulates downstream genes of NF-κB pathway
[0097] Experiments were performed using qRT-PCR methods as described above. The primer information used for amplification is as follows:
[0098]
[0099]
[0100] image 3 It shows that the low expression of CDC20 provided by the embodiment of the invention promotes the high expression of NF-κB downstream genes. image 3 A-3D shows that after TNF-α was treated for 0.5 hours, the qRT-PCR results showed that the expression levels of NF-κB downstream genes IL-8, IL-6, and ICAM1 in the CDC20 knockdown group were significantly increased.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com